search
Back to results

Morphine Consumption in Thoracotomy

Primary Purpose

Postoperative Pain

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
PVB
ESPB
Sponsored by
Kirsehir Ahi Evran University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Postoperative Pain focused on measuring Postoperative pain, Thoracotomy, Paravertebral block, Erector spina plane block

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA I-III patients undergo elective thoracotomy surgeries.

Exclusion Criteria:

  • Obesity (BMI > 35 kg/m2)
  • Infection of the skin at the site of the needle puncture area
  • Patients with known allergies to any of the study drugs
  • Coagulopathy

Sites / Locations

  • Kocaeli Unversity

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

PVB Group

ESPB group

Arm Description

Paravertebral block administered group

Erector spinae plane block administered group

Outcomes

Primary Outcome Measures

Morphine consumption
Morphine consumption (mg) of patients with patient controlled analgesia device
NRS score
Numerating rating scale of the patients (between 0 and 10, 0 represents no pain and 10 represents the worst pain ever possible.

Secondary Outcome Measures

Full Information

First Posted
August 5, 2021
Last Updated
January 25, 2022
Sponsor
Kirsehir Ahi Evran University
search

1. Study Identification

Unique Protocol Identification Number
NCT04999319
Brief Title
Morphine Consumption in Thoracotomy
Official Title
Comparison of Morphine Consumption at Postoperative 24th Hour in Thoracotomy: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
October 15, 2020 (Actual)
Primary Completion Date
January 5, 2022 (Actual)
Study Completion Date
January 25, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kirsehir Ahi Evran University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Importance of effective postoperative pain management is well known. The undesired effects of pain can be prevented with multimodal analgesia for the patient. Thoracotomy operations are associated with high levels of pain. With the use of ultrasound, many regional anesthesia techniques were described to provide effective postoperative analgesia. The aim of this study was to compare the postoperative effect of paravertebral block (PVB) and erector spinal plane block (ESPB) in thoracotomies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
Postoperative pain, Thoracotomy, Paravertebral block, Erector spina plane block

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
44 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PVB Group
Arm Type
Active Comparator
Arm Description
Paravertebral block administered group
Arm Title
ESPB group
Arm Type
Active Comparator
Arm Description
Erector spinae plane block administered group
Intervention Type
Procedure
Intervention Name(s)
PVB
Intervention Description
Paravertebral block will be performed before the surgery with 20 mL of %0.5 bupivacaine at T4 level.
Intervention Type
Procedure
Intervention Name(s)
ESPB
Intervention Description
Erector spinae plane block will be performed before the surgery with 20 mL of %0.5 bupivacaine at T4 level.
Primary Outcome Measure Information:
Title
Morphine consumption
Description
Morphine consumption (mg) of patients with patient controlled analgesia device
Time Frame
Postoperative 24th hour
Title
NRS score
Description
Numerating rating scale of the patients (between 0 and 10, 0 represents no pain and 10 represents the worst pain ever possible.
Time Frame
Postoperative 24th hour

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA I-III patients undergo elective thoracotomy surgeries. Exclusion Criteria: Obesity (BMI > 35 kg/m2) Infection of the skin at the site of the needle puncture area Patients with known allergies to any of the study drugs Coagulopathy
Facility Information:
Facility Name
Kocaeli Unversity
City
Kocaeli
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Morphine Consumption in Thoracotomy

We'll reach out to this number within 24 hrs